Recognized as one of the top 100 global CDOs, a “Power-Lady” of the German economy, and a leading Health Tech Influencer, Jessica Federer is adept at translating digital developments into meaningful advancements for both business and society. Federer is an advisor and investor for health and technology companies, and a Venture Affiliate Partner at Boston Millennia Partners.
Federer was the Chief Digital Officer at Bayer A.G., leading the global digital transformation for the life sciences leader across consumer health, pharmaceuticals, animal health, and agriculture. While at Bayer, she held positions in Global Regulatory Affairs, Market Access, Communications and Public Affairs. Federer served on the United Nations m-Powering Development Advisory Board for the Agency for Information and Communications Technology (ITU). Federer began her public health career as an analyst at the Agency for Healthcare Research and Quality in the US Department of Health and Human Services. Federer earned a Bachelor of Science from the George Washington University, and a Master of Public Health from Yale. She and her husband live in New York City.
The digital transformation of pharma is accelerating a change in business models, shifting the focus from products to outcomes. This value-based approach to medicine means radical changes for the centuries old industry as it adapts to changing regulations, payment structures and data access. This session with one of the first Chief Digital Officers in the pharmaceutical industry will explain the changes in the industry, and the promise it holds for improving both research, patient care, and deeper collaboration with providers and payers.